MedPath

Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency

Not Applicable
Completed
Conditions
Adrenal Insufficiency, Congenital
Interventions
Other: Continuous blood glucose measurement
Other: Measurement of capillary blood glucose
Registration Number
NCT04322435
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

Children with congenital primary and secondary adrenal insufficiency, who are deficient in cortisol, are at risk for hypoglycaemia, irrespective of appropriate hydrocortisone treatment, which can lead to potentially serious neurological complications. Few series are described in pediatrics. The prevalence of hypoglycaemia is probably underestimated because it is often asymptomatic and capillary blood glucose monitoring is not always performed routinely.

The objective of the study is to evaluate the prevalence of hypoglycaemia in children with adrenal insufficiency.

Detailed Description

Children with congenital primary and secondary adrenal insufficiency, who are deficient in cortisol, are at risk for hypoglycaemia, irrespective of appropriate hydrocortisone treatment, which can lead to potentially serious neurological complications. Few series are described in pediatrics. The prevalence of hypoglycaemia is underestimated because it is often asymptomatic and capillary blood glucose monitoring is not always performed routinely.

The objective of the study is to evaluate the prevalence of hypoglycaemia in children with congenital adrenal insufficiency.

The study will follow for one year children from 6 months to 6 years, with central and peripheral adrenal insufficiency.

4 study times are planned with two measurement methods:

* Continuous blood glucose measurement with Abbott Freestyle Pro for 14 days, repeated twice at 6 months intervals.

* Measurement of capillary blood glucose, in the morning on an empty stomach, every first week of each month for 12 months, with Abbott's Freestyle optium neo reader, used with the Accu-Chek FastClix lancing device and the test strips Accu-Chek performed.

* Measurement of capillary glycaemia in case of suspicion of hypoglycaemia. Measure left free according to the judgment of the parents of the necessary character or not. With Abbott's Freestyle optium neo reader, used with the Accu-Chek FastClix lancing device and the Accu-Chek performa strips.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • All male and female patients, followed in the Paediatric Endocrinology Department at Necker Hospital, with congenital primary and secondary adrenal insufficiency.
  • Age between 6 months and 6 years.
  • Included in the social security system.
  • Parental consent and willingness to participate in this study: involves training and skills in the use of blood glucometers.
Exclusion Criteria
  • Patients with acquired adrenal insufficiency.
  • Patients with type 1 or type 2 diabetes.
  • Patients with somatotropic deficiency associated with adrenal insufficiency.
  • Refusal or impossibility to perform the glycaemic measurements according to the procedure of the study.
  • Not covered by the social security system.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adrenal insufficiencyMeasurement of capillary blood glucosePatients followed in the paediatric endocrinology department of the Necker Hospital, with primary and secondary adrenal insufficiency, aged from 6 months to 6 years.
Adrenal insufficiencyContinuous blood glucose measurementPatients followed in the paediatric endocrinology department of the Necker Hospital, with primary and secondary adrenal insufficiency, aged from 6 months to 6 years.
Primary Outcome Measures
NameTimeMethod
Prevalence of hypoglycaemia1 year

Number of hypoglycaemic events. Hypoglycaemia will be defined by a glucose level measured at a glucose level of less than or equal to 0.55 g /L (3 mmol /L).

Secondary Outcome Measures
NameTimeMethod
Body Mass Index1 year

Body mass divided by the square of the body height expressed in units of kg/m2 : mass in kilograms and height in meters

Heart rate1 year

Number of beats per minute

Stade tanner1 year

stade tanner A1 to A5

Duration of hypoglycaemia1 year

Time in hypoglycaemia measured in minutes per day during the continuous blood glucose measurements.

Percentage of time in hypoglycaemia1 year

Percentage of time in hypoglycaemia during the continuous blood glucose measurements.

Glycemic variations rate1 year

Glycemic variations rate during the different measurements times: minimum rate, maximum rate, average, median. Each result will be expressed in g /L or in mmol /L. Each date will expressed by one day and for one week.

Circumstances of occurrence of hypoglycaemia1 year

Circumstances in which hypoglycaemia occurred : descriptive data by parents, symptomatic or not symptomatic hypoglycaemia, descriptive signs if they are presents.

Testosterone1 year

Nanomole per liter

Systolic and Diastolic Blood Pressure1 year

Expressed millimetre of mercury

Amount of salt consumed per day1 year

Number of grams per day

Adreno CorticoTropic Hormone1 year

Nanogram per liter

Cortisol at 8 a.m.1 year

microgram / deciliter

17-hydroxyprogesterone1 year

Nanomole per liter

Ionogram1 year

Nanomole per liter

Renin1 year

picogram/milliliter

Occurrence of medical events1 year

Events during the follow-up of the study: modification of treatment of hydrocortisone and fludrocortisone, re-sugaring expressed in number of sugar cubes ( by sugar cube = 20 gr of sugar) or type of sweet food given to the child, hospitalizations ( type and reason for hospitalization, cause of the decompensation).

Cycle of 17-hydroxyprogesterone1 year

Nanomole per liter

Delta-4-Androstenedione1 year

Nanomole per liter

Trial Locations

Locations (1)

Hôpital Necker-Enfants Malades

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath